Table I.
Times (days), mean ± Sχ̄ |
||||||
---|---|---|---|---|---|---|
Groups | 0 | 2 | 4 | 6 | 8 | 10 |
Anti-inflammatory period | ||||||
Control group (n = 5) | 38.52 ± 4.67a | 55.70 ± 9.32a | 65.30 ± 3.04b | 75.75 ± 11.07b | 56.85 ± 9.05a | 38.66 ± 3.20a |
CL group (n = 11) | 38.79 ± 2.94a | 52.92 ± 2.55b | 58 ± 3.34b | 97.44 ± 6.03b | 47.58 ± 4.06a | 34.11 ± 1.89a |
Immunosuppressive period | ||||||
Control group (n = 5) | 34.22 ± 3.36a | 74.03 ± 9.62b | 78.33 ± 4.04b | 84.49 ± 8.45b | 68.88 ± 8.68b | 34.51 ± 5.32a |
CL group (n = 11) | 43.87 ± 2.79a | 76.48 ± 5.22b | 71.34 ± 5.12b | 78.37 ± 8b | 68.41 ± 3.95b | 30.66 ± 3.46a |
CL — Canine leishmaniosis
Different superscripts represent a significant difference (P < 0.05)